• Orifarm/
  • About Us/
  • Our history

    Our history

    With a strong vision, albeit limited experience and knowledge of the pharmaceutical industry, Birgitte and Hans Bøgh-Sørensen has grown Orifarm from a “two-owners-one-employee” company to an international organization with offices across Europe and in the United States.

    Starting out with a strong entrepreneurial mission to make high-quality pharmaceuticals a better deal for patients, society, and Orifarm, Birgitte and Hans Bøgh-Sørensen have grown Orifarm from a small danish company in 1994 into an impressive international organization employing more than 2,300 colleagues.

    Birgitte and Hans Bøgh-Sørensen
    A family-owned company

    Orifarm is a family-owned company. The company was founded in Odense, Denmark, in 1994 by Birgitte and Hans Bøgh-Sørensen. Today, Orifarm is owned by the founding couple and their three grown-up children, Christian, Anne-Charlotte, and Andreas Bøgh-Sørensen. Nearly 30 years after the foundation of Orifarm, owners Birgitte and Hans Bøgh-Sørensen still remain heavily involved in the continuous long-term development of Orifarm.

    Erik Sandberg, CEO
    Appointment of our CEO Erik Sandberg

    In January 2019, Hans Bøgh-Sørensen stepped down as CEO and handed over control of the daily business to Group CEO Erik Sandberg.

    However, Hans Bøgh-Sørensen remained a member of the Board of Directors, and in August 2020, he took over as Chairman of the Board of Directors of Orifarm Group.

    Hans Bøgh-Sørensen
    Chairman of the Board of Directors

    Having appointed a new CEO to control daily business, Hans Bøgh-Sørensen remains a member of the Board of Directors, and in August 2020, he took over as Chairman of the Board of Directors of Orifarm Group.

    History Overview

    1994: Orifarm was founded by Birgitte and Hans Bøgh-Sørensen.

    Organic growth within Orifarm Health Access to the rest of the Nordic countries and Orifarm Healthcare starts.

    Acquisition of Pharma Western, Germany (Orifarm Health Access).

    Profit focus and split of Orifarm Trade and Orifarm Healthcare + establishment of professional and international Board of Directors.

    Production and inbound logistics setup in the Czech Republic.

    Orifarm acquires Growth House Holding, including the companies Alternova, Viminco, and Pilum Pharma.

    Entry in the Netherlands, the United Kingdom, and Austria.

    Orifarm acquires the company Pilatus Comparator Solutions, with activities in the U.K., Germany, and the U.S.

    Acquisition from Takeda. The acquisition includes more than 100 pharmaceuticals and dietary supplements, as well as approximately 600 employees.

    To ensure Orifarm remains family-owned in the future, the next step of the succession is completed, as Birgitte and Hans Bøgh-Sørensen transfer further company shares to their three children. Hans Bøgh-Sørensen remains Chairman of the Board of Directors and continues to have the majority voting right.

    Orifarm focuses on building the foundation for further growth, as the company continues to grow into a larger, international player.

    Always aiming higher

    For us, achieving one goal means setting a new one. We have a history of increasing turnover, and our ambition is to keep raising the bar - for Orifarm and for our customers.

    Revenue graph
    Bøgh-Sørensen family Bøgh-Sørensen family